Quimby Investments

Variational AI is a biotechnology company that leverages advanced machine learning techniques to efficiently generate novel compounds optimized for multiple therapeutic properties. Focused on drug discovery, the company aims to address key challenges in the pharmaceutical industry, particularly those related to drug attrition and the likelihood of clinical success. Variational AI specializes in developing selective kinase inhibitors for solid tumor indications and has plans to expand its target classes. By collaborating with leading biopharmaceutical partners and building an internal pipeline, the company enables faster identification of drug-like molecules that are potent, selective, safe, and synthesizable. Its innovative approach aims to reduce the time necessary for molecular optimization and enhance the success rates of drug development.

Arbutus Medical Inc. is a Vancouver-based company that specializes in the development and manufacturing of surgical power tools for orthopedic surgeries. Founded in 2014, the company focuses on creating cost-effective and user-friendly devices, including its flagship orthopedic power tool system, which is designed to be affordable and accessible. Arbutus Medical aims to address the rising costs of healthcare by offering innovative solutions that enhance access to orthopedic surgery for millions of patients, particularly in low- and middle-income countries. Its product portfolio includes various tools and sterile-packed procedure kits, such as the HEX drill kit and PRO drill kit, which are utilized in North American trauma centers, veterinary hospitals, military deployments, and humanitarian missions. Through its commitment to "frugal innovation," Arbutus Medical seeks to improve surgical outcomes while reducing expenses for healthcare providers.

LightIntegra Technology Inc., established in 2009 and headquartered in Vancouver, Canada, is a privately-funded medical diagnostics company specializing in innovative in-vitro diagnostic tests. The company's flagship product, ThromboLUX, is designed to provide healthcare professionals with qualitative and quantitative information about microparticle content in platelet samples. LightIntegra offers the ThromboLUX test kit, control kit, and ThromboSight, a software tool for analyzing test results. Founded by Dr. Elisabeth Maurer, a research scientist from Canadian Blood Services R&D labs, the company aims to minimize platelet refractoriness through its products.